Slocum, Gordon & CO LLP Zoetis Inc. Transaction History
Slocum, Gordon & CO LLP
- $115 Million
- Q4 2024
A detailed history of Slocum, Gordon & CO LLP transactions in Zoetis Inc. stock. As of the latest transaction made, Slocum, Gordon & CO LLP holds 1,942 shares of ZTS stock, worth $338,141. This represents 0.28% of its overall portfolio holdings.
Number of Shares
1,942
Previous 1,942
-0.0%
Holding current value
$338,141
Previous $379,000
16.62%
% of portfolio
0.28%
Previous 0.07%
Shares
1 transactions
Others Institutions Holding ZTS
# of Institutions
1,969Shares Held
413MCall Options Held
1.01MPut Options Held
1.08M-
Vanguard Group Inc Valley Forge, PA41.2MShares$7.18 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$6.41 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.8MShares$3.44 Billion0.16% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL16MShares$2.79 Billion2.73% of portfolio
-
Alliancebernstein L.P. New York, NY15.4MShares$2.68 Billion1.05% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $81.5B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...